Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study page is now shown as a 403 Forbidden error, replacing the usual study details and navigation with an access-denied screen.SummaryDifference18%

- Check37 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor version update to the page; no study data or visible content appears to be altered.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5. This appears to be a minor maintenance update with no observable changes to the study details or user-facing content.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a newer revision of the page content. This is a metadata update and does not alter the displayed study details.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a minor update to the page metadata. This change does not modify the study content or visible user-facing information.SummaryDifference0.1%

- Check101 days agoChange DetectedThe page revision indicator was updated from v3.6.0 to v3.6.2, representing a minor system or editorial update and not a change to the study details or visible content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.